Low use of guideline-recommended treatment among Medicare Advantage and traditional Medicare beneficiaries with advanced lung cancer

Journal of Geriatric Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles